(EMAILWIRE.COM, December 14, 2021 ) The chromatography resin market is projected to reach USD 3.3 billion by 2025, at a CAGR of 8.2% from USD 2.2 billion in 2020. Chromatography resin is a matrix made of natural and synthetic polymers (dextran, cellulose, and agarose) or inorganic materials (silica and polyacrylamide). This matrix separates or purifies complex mixtures by a set of techniques. The base resin is attached to ligands based on different applications, such as pharmaceutical & biotechnology, food & beverage, and water & environmental analysis.

Natural polymer is the largest type segment of the chromatography resin market. North America was the largest market for chromatography resin in 2019, in terms of both volume and value. Factors such as increasing demand for therapeutic antibodies, public-private investment in pharmaceutical & life science research, and rising concern for food safety will drive the chromatography resin market.

To know about the assumptions considered for the study download the pdf brochure

North America accounts for the largest share of the overall chromatography resin market in terms of both volume and value. A strong therapeutic monoclonal antibody market in North America is the key driver for resin sale in this segment. Modern chromatographic techniques are also increasingly used in food analytics and other diagnostic purposes in the US as well as in Canada. The key suppliers in the region include Bio-Rad (US), Thermo Fisher (US), and Repligen (US). Almost all the key pharmaceutical companies have their research centers in North America. The region has been leading the way in the R&D of biopharmaceuticals. The North American chromatography resin market is primarily driven by the increasing demand for monoclonal antibodies, rising R&D expenditure by pharmaceutical and biotechnology companies, and the presence of major players in the region.

The North American region has a diverse and well-established R&D infrastructure. This market is witnessing a rapid adoption of chromatography techniques among major end-user categories owing to supportive government regulation and significant availability of research funding and private investments.

Europe is estimated to be the second largest chromatography resin market during the forecast period.

Europe was the second-largest market for chromatography resin, in terms of value, in 2019. Germany is the key market for chromatography resins in Europe. Other countries, such as Austria and Switzerland, are also significant markets for chromatography resins. The presence of a number of pharmaceutical manufacturers and research organizations in these countries impacts the market growth of chromatography resins in Europe. The increase in critical diseases in Europe is expected to drive the antibody therapeutics market in this region for the next decade. This, in turn, will result in high demand for chromatography resin in downstream applications. However, the highly regulated biologics sector in Europe is a key challenge for resin suppliers. Regulatory bodies, including European Medicines Agency (EMA) and European Commission (EC), have laid down extremely stringent guidelines, according to which biologic and biosimilars drug manufacturers submit robust data to showcase a product’s efficacy and safety profile.

The key market players profiled in the report include Bio-Rad Laboratories (US), GE Healthcare (US), Merch KGaA (Germany), Thermo Fisher Scientific Inc. (US), Cytiva (US), Tosoh Corporation (Japan), Sartorius Stedim Biotech S.A. (France), Bio-Works Technologies AB (Sweden), Avantor Performance Materials, Inc. (US), Mitsubishi Chemical Corporation (Japan), Purolite Corporation (US), and Repligen Corporation (US).

Request for Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=933

Contact Information:
MarketsandMarkets™
Mr. Aashish Mehra
Tel: 1-888-600-6441
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results